BVS Earnings

BVS reported its earnings on 2026-03-23, showcasing a revenue of against an estimate of 152.69M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.22 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following BVS's earnings announcement on 2026-03-23, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, BVS's stock price tends to shift by an average of -3.86% in the 10 days leading up to earnings and 1.4% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate BVS's annual revenue to reach 155.70M, while the EPS is projected at 0.21. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BVS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BVS's stock price typically moves by -3.86% in the 10 days before its earnings and 1.4% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.21 and revenue of 155.70M.

The earnings call highlighted strong financial performance with 8% organic revenue growth, 13% EBITDA increase, and a 200% rise in EPS. Despite tariff impacts, gross margins remained robust. The Q&A section revealed optimism about product lines and market expansion, with positive feedback on new offerings. The company maintained guidance, indicating confidence. However, lack of specific future guidance slightly tempers the outlook. Overall, the financial health and strategic initiatives suggest a positive stock price movement.